Skip to main content
Top

07-05-2024 | Interferon | RESEARCH

Esaxerenone Inhibits Interferon-γ Induced Pyroptosis of Macrophages in the Lungs of Aldosterone-treated Mice

Authors: Jingyue Chang, Xiaomeng Gao, Fan Yang, Panpan Qiang, Lili Fan, Ziqian Liu, Tatsuo Shimosawa, Qingyou Xu, Yi Chang

Published in: Inflammation

Login to get access

Abstract

Lung immune cells such as lymphocytes and macrophages can induce an inflammatory response due to the activation of mineralocorticoid receptor (MR), which is manifested by the infiltration of inflammatory cells and the secretion of inflammatory cytokines and subsequent apoptosis, pyroptosis and necrosis of intrinsic lung cells and immune cells. Macrophages are immune cells that are abundant in the lung and act as the first line of defense against pathogens but are also aggravating factors of infection. The activation of the renin-angiotensin-aldosterone system (RAAS), especially aldosterone-stimulated MR activation, can induce macrophage and CD8+ T cell aggregation and the secretion of cytokines such as tumor necrosis factor-α (TNF-α) and interferon-gamma (IFN-γ). Increased IFN-γ secretion can induce macrophage pyroptosis and the release of interleukin 1-β (IL-1β), aggravating lung injury. In this study, lung injury in C57BL/6 mice was induced by subcutaneous micro-osmotic pump infusion of aldosterone. After 12 weeks of administration, the kidney, heart, blood vessels and lungs all showed obvious inflammatory injury, which manifested as rapid accumulation of macrophages. The overexpression of IFN-γ in the lungs of aldosterone-treated mice and the stimulation of MH-S and RAW264.7 alveolar macrophages (AMs) with aldosterone in vitro showed that IFN-γ induced pyroptosis of macrophages via the activation of the inflammasome, and the MR blocker esaxerenone effectively inhibited this effect and alleviated lung injury. In addition, IFN-γ secreted by CD8+ T cells is associated with macrophage pyroptosis. In conclusion, the inhibition of macrophage pyroptosis can effectively alleviate lung injury.
Appendix
Available only for authorised users
Literature
1.
go back to reference Robinson, N., R. Ganesan, C. Hegedus, K. Kovacs, T.A. Kufer, and L. Virag. 2019. Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos. Redox Biology 26: 101239.CrossRefPubMedPubMedCentral Robinson, N., R. Ganesan, C. Hegedus, K. Kovacs, T.A. Kufer, and L. Virag. 2019. Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos. Redox Biology 26: 101239.CrossRefPubMedPubMedCentral
2.
go back to reference Shi, J., Y. Zhao, K. Wang, X. Shi, Y. Wang, H. Huang, et al. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526: 660–665.CrossRefPubMed Shi, J., Y. Zhao, K. Wang, X. Shi, Y. Wang, H. Huang, et al. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526: 660–665.CrossRefPubMed
3.
go back to reference Shotland, A.M., A.P. Fontenot, and A.S. McKee. 2021. Pulmonary macrophage cell death in lung health and disease. American Journal of Respiratory Cell and Molecular Biology 64: 547–556.CrossRefPubMedPubMedCentral Shotland, A.M., A.P. Fontenot, and A.S. McKee. 2021. Pulmonary macrophage cell death in lung health and disease. American Journal of Respiratory Cell and Molecular Biology 64: 547–556.CrossRefPubMedPubMedCentral
4.
go back to reference Han, C.H., P.X. Zhang, and W.W. Liu. 2017. Macrophage polarization is related to the pathogenesis of decompression induced lung injury. Medical Gas Research 7: 220–223.CrossRefPubMedPubMedCentral Han, C.H., P.X. Zhang, and W.W. Liu. 2017. Macrophage polarization is related to the pathogenesis of decompression induced lung injury. Medical Gas Research 7: 220–223.CrossRefPubMedPubMedCentral
6.
go back to reference Cai, Y., C. Sugimoto, M. Arainga, X. Alvarez, E.S. Didier, and M.J. Kuroda. 2014. In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: Implications for understanding lung disease in humans. The Journal of Immunology 192: 2821–2829.CrossRefPubMed Cai, Y., C. Sugimoto, M. Arainga, X. Alvarez, E.S. Didier, and M.J. Kuroda. 2014. In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: Implications for understanding lung disease in humans. The Journal of Immunology 192: 2821–2829.CrossRefPubMed
7.
go back to reference Ma, Y., Z. Wang, X. Wu, Z. Ma, J. Shi, S. He, et al. 2023. 5-Methoxytryptophan ameliorates endotoxin-induced acute lung injury in vivo and in vitro by inhibiting NLRP3 inflammasome-mediated pyroptosis through the Nrf2/HO-1 signaling pathway. Inflammation Research 72: 1633–1647.CrossRefPubMed Ma, Y., Z. Wang, X. Wu, Z. Ma, J. Shi, S. He, et al. 2023. 5-Methoxytryptophan ameliorates endotoxin-induced acute lung injury in vivo and in vitro by inhibiting NLRP3 inflammasome-mediated pyroptosis through the Nrf2/HO-1 signaling pathway. Inflammation Research 72: 1633–1647.CrossRefPubMed
8.
go back to reference Wu, Y.T., W.T. Xu, L. Zheng, S. Wang, J. Wei, M.Y. Liu, et al. 2023. 4-octyl itaconate ameliorates alveolar macrophage pyroptosis against ARDS via rescuing mitochondrial dysfunction and suppressing the cGAS/STING pathway. International Immunopharmacology 118: 110104.CrossRefPubMed Wu, Y.T., W.T. Xu, L. Zheng, S. Wang, J. Wei, M.Y. Liu, et al. 2023. 4-octyl itaconate ameliorates alveolar macrophage pyroptosis against ARDS via rescuing mitochondrial dysfunction and suppressing the cGAS/STING pathway. International Immunopharmacology 118: 110104.CrossRefPubMed
9.
go back to reference Zhao, Z., Y. Ming, X. Li, H. Tan, X. He, L. Yang, et al. 2023. Hyperglycemia aggravates periodontitis via autophagy impairment and ROS-inflammasome-mediated macrophage pyroptosis. International Journal of Molecular Sciences 24: 6309.CrossRefPubMedPubMedCentral Zhao, Z., Y. Ming, X. Li, H. Tan, X. He, L. Yang, et al. 2023. Hyperglycemia aggravates periodontitis via autophagy impairment and ROS-inflammasome-mediated macrophage pyroptosis. International Journal of Molecular Sciences 24: 6309.CrossRefPubMedPubMedCentral
11.
go back to reference Bruder-Nascimento, T., N.S. Ferreira, C.Z. Zanotto, F. Ramalho, I.O. Pequeno, V.C. Olivon, et al. 2016. NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage. Circulation 134: 1866–1880.CrossRefPubMed Bruder-Nascimento, T., N.S. Ferreira, C.Z. Zanotto, F. Ramalho, I.O. Pequeno, V.C. Olivon, et al. 2016. NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage. Circulation 134: 1866–1880.CrossRefPubMed
12.
go back to reference Li, Y., Y. Zhang, T. Chen, Y. Huang, Y. Zhang, S. Geng, et al. 2020. Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome. Journal of Gastroenterology and Hepatology 35: 1069–1077.CrossRefPubMed Li, Y., Y. Zhang, T. Chen, Y. Huang, Y. Zhang, S. Geng, et al. 2020. Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome. Journal of Gastroenterology and Hepatology 35: 1069–1077.CrossRefPubMed
13.
go back to reference Ferreira, N.S., T. Bruder-Nascimento, C.A. Pereira, C.Z. Zanotto, D.S. Prado, J.F. Silva, et al. 2019. NLRP3 Inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus. Cells 8: 1595.CrossRefPubMedPubMedCentral Ferreira, N.S., T. Bruder-Nascimento, C.A. Pereira, C.Z. Zanotto, D.S. Prado, J.F. Silva, et al. 2019. NLRP3 Inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus. Cells 8: 1595.CrossRefPubMedPubMedCentral
14.
go back to reference Ma, X., Y. Chang, Y. Xiong, Z. Wang, X. Wang, and Q. Xu. 2019. Eplerenone ameliorates cell pyroptosis in contralateral kidneys of rats with unilateral ureteral obstruction. Nephron 142: 233–242.CrossRefPubMed Ma, X., Y. Chang, Y. Xiong, Z. Wang, X. Wang, and Q. Xu. 2019. Eplerenone ameliorates cell pyroptosis in contralateral kidneys of rats with unilateral ureteral obstruction. Nephron 142: 233–242.CrossRefPubMed
15.
go back to reference Yang, F., Y. Chang, C. Zhang, Y. Xiong, X. Wang, X. Ma, et al. 2021. UUO induces lung fibrosis with macrophage-myofibroblast transition in rats. International Immunopharmacology 93: 107396.CrossRefPubMed Yang, F., Y. Chang, C. Zhang, Y. Xiong, X. Wang, X. Ma, et al. 2021. UUO induces lung fibrosis with macrophage-myofibroblast transition in rats. International Immunopharmacology 93: 107396.CrossRefPubMed
16.
go back to reference Martin-Fernandez, B., A. Rubio-Navarro, I. Cortegano, S. Ballesteros, M. Alia, P. Cannata-Ortiz, et al. 2016. Aldosterone induces renal fibrosis and inflammatory m1-macrophage subtype via mineralocorticoid receptor in rats. PLoS ONE 11: e0145946.CrossRefPubMedPubMedCentral Martin-Fernandez, B., A. Rubio-Navarro, I. Cortegano, S. Ballesteros, M. Alia, P. Cannata-Ortiz, et al. 2016. Aldosterone induces renal fibrosis and inflammatory m1-macrophage subtype via mineralocorticoid receptor in rats. PLoS ONE 11: e0145946.CrossRefPubMedPubMedCentral
17.
go back to reference Kumar, V. 2020. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Frontiers in Immunology 11: 1722.CrossRefPubMedPubMedCentral Kumar, V. 2020. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Frontiers in Immunology 11: 1722.CrossRefPubMedPubMedCentral
18.
go back to reference Mills, C.D., K. Kincaid, J.M. Alt, M.J. Heilman, and A.M. Hill. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. The Journal of Immunology 164: 6166–6173.CrossRefPubMed Mills, C.D., K. Kincaid, J.M. Alt, M.J. Heilman, and A.M. Hill. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. The Journal of Immunology 164: 6166–6173.CrossRefPubMed
19.
go back to reference Chen, X., J. Tang, W. Shuai, J. Meng, J. Feng, and Z. Han. 2020. Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome. Inflammation Research 69: 883–895.CrossRefPubMedPubMedCentral Chen, X., J. Tang, W. Shuai, J. Meng, J. Feng, and Z. Han. 2020. Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome. Inflammation Research 69: 883–895.CrossRefPubMedPubMedCentral
20.
go back to reference Dang, W., Y. Tao, X. Xu, H. Zhao, L. Zou, and Y. Li. 2022. The role of lung macrophages in acute respiratory distress syndrome. Inflammation Research 71: 1417–1432.CrossRefPubMedPubMedCentral Dang, W., Y. Tao, X. Xu, H. Zhao, L. Zou, and Y. Li. 2022. The role of lung macrophages in acute respiratory distress syndrome. Inflammation Research 71: 1417–1432.CrossRefPubMedPubMedCentral
21.
go back to reference Yang, G., Y. Yang, Y. Liu, and X. Liu. 2023. Regulation of alveolar macrophage death in pulmonary fibrosis: a review. Apoptosis: An International Journal on Programmed Cell Death 28: 1505–1519.CrossRefPubMed Yang, G., Y. Yang, Y. Liu, and X. Liu. 2023. Regulation of alveolar macrophage death in pulmonary fibrosis: a review. Apoptosis: An International Journal on Programmed Cell Death 28: 1505–1519.CrossRefPubMed
22.
go back to reference Fink, S.L., and B.T. Cookson. 2007. Pyroptosis and host cell death responses during Salmonella infection. Cellular Microbiology 9: 2562–2570.CrossRefPubMed Fink, S.L., and B.T. Cookson. 2007. Pyroptosis and host cell death responses during Salmonella infection. Cellular Microbiology 9: 2562–2570.CrossRefPubMed
23.
go back to reference Wu, D.D., P.H. Pan, B. Liu, X.L. Su, L.M. Zhang, H.Y. Tan, et al. 2015. Inhibition of alveolar macrophage pyroptosis reduces lipopolysaccharide-induced acute lung injury in mice. Chinese Medical Journal (Engl) 128: 2638–2645.CrossRef Wu, D.D., P.H. Pan, B. Liu, X.L. Su, L.M. Zhang, H.Y. Tan, et al. 2015. Inhibition of alveolar macrophage pyroptosis reduces lipopolysaccharide-induced acute lung injury in mice. Chinese Medical Journal (Engl) 128: 2638–2645.CrossRef
24.
go back to reference Shi, J., W. Gao, and F. Shao. 2017. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends in Biochemical Sciences 42: 245–254.CrossRefPubMed Shi, J., W. Gao, and F. Shao. 2017. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends in Biochemical Sciences 42: 245–254.CrossRefPubMed
25.
go back to reference Heilig, R., M.S. Dick, L. Sborgi, E. Meunier, S. Hiller, and P. Broz. 2018. The Gasdermin-D pore acts as a conduit for IL-1beta secretion in mice. European Journal of Immunology 48: 584–592.CrossRefPubMed Heilig, R., M.S. Dick, L. Sborgi, E. Meunier, S. Hiller, and P. Broz. 2018. The Gasdermin-D pore acts as a conduit for IL-1beta secretion in mice. European Journal of Immunology 48: 584–592.CrossRefPubMed
26.
go back to reference Chae, J.J., Y.H. Cho, G.S. Lee, J. Cheng, P.P. Liu, L. Feigenbaum, et al. 2011. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 34: 755–768.CrossRefPubMedPubMedCentral Chae, J.J., Y.H. Cho, G.S. Lee, J. Cheng, P.P. Liu, L. Feigenbaum, et al. 2011. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 34: 755–768.CrossRefPubMedPubMedCentral
27.
28.
go back to reference McVey, M.J., B.E. Steinberg, and N.M. Goldenberg. 2021. Inflammasome activation in acute lung injury. American Journal of Physiology Lung Cellular and Molecular Physiology 320: L165–L178.CrossRefPubMed McVey, M.J., B.E. Steinberg, and N.M. Goldenberg. 2021. Inflammasome activation in acute lung injury. American Journal of Physiology Lung Cellular and Molecular Physiology 320: L165–L178.CrossRefPubMed
29.
go back to reference He, X., Y. Qian, Z. Li, E.K. Fan, Y. Li, L. Wu, et al. 2016. TLR4-Upregulated IL-1beta and IL-1RI promote alveolar macrophage pyroptosis and lung inflammation through an autocrine mechanism. Science and Reports 6: 31663.CrossRef He, X., Y. Qian, Z. Li, E.K. Fan, Y. Li, L. Wu, et al. 2016. TLR4-Upregulated IL-1beta and IL-1RI promote alveolar macrophage pyroptosis and lung inflammation through an autocrine mechanism. Science and Reports 6: 31663.CrossRef
30.
go back to reference Bauernfeind, F.G., G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, et al. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. The Journal of Immunology 183: 787–791.CrossRefPubMed Bauernfeind, F.G., G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, et al. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. The Journal of Immunology 183: 787–791.CrossRefPubMed
31.
go back to reference Foley, A., B.E. Steinberg, and N.M. Goldenberg. 2021. Inflammasome activation in pulmonary arterial hypertension. Frontiers in Medicine (Lausanne) 8.CrossRef Foley, A., B.E. Steinberg, and N.M. Goldenberg. 2021. Inflammasome activation in pulmonary arterial hypertension. Frontiers in Medicine (Lausanne) 8.CrossRef
32.
go back to reference Liaudet, L., and C. Szabo. 2020. Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease. Critical Care 24: 318.CrossRefPubMedPubMedCentral Liaudet, L., and C. Szabo. 2020. Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease. Critical Care 24: 318.CrossRefPubMedPubMedCentral
33.
go back to reference Henriquez, A.R., S.J. Snow, M.C. Schladweiler, C.N. Miller, J.A. Dye, A.D. Ledbetter, et al. 2018. Adrenergic and glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation. Toxicology and Applied Pharmacology 339: 161–171.CrossRefPubMed Henriquez, A.R., S.J. Snow, M.C. Schladweiler, C.N. Miller, J.A. Dye, A.D. Ledbetter, et al. 2018. Adrenergic and glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation. Toxicology and Applied Pharmacology 339: 161–171.CrossRefPubMed
34.
go back to reference Ivashkiv, L.B. 2018. IFNgamma: Signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nature Reviews Immunology 18: 545–558.CrossRefPubMedPubMedCentral Ivashkiv, L.B. 2018. IFNgamma: Signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nature Reviews Immunology 18: 545–558.CrossRefPubMedPubMedCentral
35.
go back to reference Mezouar, S., and J.L. Mege. 2020. Changing the paradigm of IFN-gamma at the interface between innate and adaptive immunity: Macrophage-derived IFN-gamma. Journal of Leukocyte Biology 108: 419–426.CrossRefPubMed Mezouar, S., and J.L. Mege. 2020. Changing the paradigm of IFN-gamma at the interface between innate and adaptive immunity: Macrophage-derived IFN-gamma. Journal of Leukocyte Biology 108: 419–426.CrossRefPubMed
36.
go back to reference Simpson, D.S., J. Pang, A. Weir, I.Y. Kong, M. Fritsch, M. Rashidi, et al. 2022. Interferon-gamma primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway. Immunity 55 (423–441): e9. Simpson, D.S., J. Pang, A. Weir, I.Y. Kong, M. Fritsch, M. Rashidi, et al. 2022. Interferon-gamma primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway. Immunity 55 (423–441): e9.
37.
go back to reference Chin, Y.E., M. Kitagawa, K. Kuida, R.A. Flavell, and X.Y. Fu. 1997. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Molecular and Cellular Biology 17: 5328–5337.CrossRefPubMedPubMedCentral Chin, Y.E., M. Kitagawa, K. Kuida, R.A. Flavell, and X.Y. Fu. 1997. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Molecular and Cellular Biology 17: 5328–5337.CrossRefPubMedPubMedCentral
38.
go back to reference Karki, R., B.R. Sharma, S. Tuladhar, E.P. Williams, L. Zalduondo, P. Samir, et al. 2021. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184 (149–168): e17. Karki, R., B.R. Sharma, S. Tuladhar, E.P. Williams, L. Zalduondo, P. Samir, et al. 2021. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184 (149–168): e17.
39.
go back to reference Narumi, S., J.M. Tebo, J.H. Finke, and T.A. Hamilton. 1992. IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages. The Journal of Immunology 149: 529–534.CrossRefPubMed Narumi, S., J.M. Tebo, J.H. Finke, and T.A. Hamilton. 1992. IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages. The Journal of Immunology 149: 529–534.CrossRefPubMed
Metadata
Title
Esaxerenone Inhibits Interferon-γ Induced Pyroptosis of Macrophages in the Lungs of Aldosterone-treated Mice
Authors
Jingyue Chang
Xiaomeng Gao
Fan Yang
Panpan Qiang
Lili Fan
Ziqian Liu
Tatsuo Shimosawa
Qingyou Xu
Yi Chang
Publication date
07-05-2024
Publisher
Springer US
Keyword
Interferon
Published in
Inflammation
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-024-02030-5
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.